Difficulty: Medium
Average Score: 78%
Practice
A newborn is diagnosed with persistent pulmonary hypertension (PPHN). Which of the following interventions is most commonly used to treat PPHN?
Correct answer
A
Rationale
In pediatric nursing, understanding the management of conditions like persistent pulmonary hypertension (PPHN) is crucial for providing effective care to newborns. The correct intervention for treating PPHN is inhaled nitric oxide (Option A). Nitric oxide is a potent pulmonary vasodilator that helps improve oxygenation by dilating pulmonary blood vessels and reducing pulmonary vascular resistance, thus increasing blood flow to the lungs. This ultimately improves oxygenation and reduces the risk of hypoxemia in newborns with PPHN.
Option B, magnesium sulfate, is not commonly used to treat PPHN. Magnesium sulfate is typically used in obstetrics for conditions like preeclampsia or eclampsia to prevent seizures.
Option C, surfactant therapy, is used for conditions like respiratory distress syndrome (RDS) in newborns, where there is a deficiency of surfactant in the lungs, leading to atelectasis and poor oxygenation. PPHN, however, is primarily a vascular issue rather than a surfactant deficiency.
Option D, continuous positive airway pressure (CPAP), is a supportive therapy used in conditions like respiratory distress syndrome (RDS) or apnea of prematurity to help keep the airways open and improve oxygenation. While CPAP may be part of the overall management of PPHN, it is not the primary intervention for treating PPHN.
Educationally, nurses need to understand the specific pharmacological interventions for different respiratory conditions in newborns to provide safe and effective care. Knowing the rationale behind using inhaled nitric oxide for PPHN empowers nurses to advocate for the most appropriate treatment and monitor for desired outcomes in newborns with this condition.
Option B, magnesium sulfate, is not commonly used to treat PPHN. Magnesium sulfate is typically used in obstetrics for conditions like preeclampsia or eclampsia to prevent seizures.
Option C, surfactant therapy, is used for conditions like respiratory distress syndrome (RDS) in newborns, where there is a deficiency of surfactant in the lungs, leading to atelectasis and poor oxygenation. PPHN, however, is primarily a vascular issue rather than a surfactant deficiency.
Option D, continuous positive airway pressure (CPAP), is a supportive therapy used in conditions like respiratory distress syndrome (RDS) or apnea of prematurity to help keep the airways open and improve oxygenation. While CPAP may be part of the overall management of PPHN, it is not the primary intervention for treating PPHN.
Educationally, nurses need to understand the specific pharmacological interventions for different respiratory conditions in newborns to provide safe and effective care. Knowing the rationale behind using inhaled nitric oxide for PPHN empowers nurses to advocate for the most appropriate treatment and monitor for desired outcomes in newborns with this condition.